Eiry Roberts - 10 Jun 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Reporting relationship: Director
Issuer ticker: FOLD
Reported as of: 10 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2021, 19:04:37 UTC
Prior SEC filing: 26 Apr 2023
Next SEC filing: 12 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Christian Formica, Attorney-in-Fact

Key filing fact

Eiry Roberts filed Form 4 for AMICUS THERAPEUTICS, INC. (FOLD) on 14 Jun 2021.

Key facts

This page summarizes Eiry Roberts's Form 4 filing for AMICUS THERAPEUTICS, INC. (FOLD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2021, 19:04.

Change

Previous filing in this sequence was filed on 26 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FOLD transaction

Common Stock

Award

Transaction value: $0
Shares: +22,759
Change %
Price: $0.000000
Shares after: 22,759
Date: 10 Jun 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FOLD transaction Derivative

Stock Options (right to buy)

Award

Transaction value: $0
Shares: +40,625
Change %
Price: $0.000000
Shares after: 40,625
Date: 10 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,625
Exercise price: $10.71
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units (RSUs) vest over a period of four years, with 25% vesting on the first anniversary of the grant date and 25% on each anniversary thereafter.

Footnote F2

These stock options vest and become exercisable over a period of four years, with 25% vesting on the first anniversary of the date of grant and the remainder vesting ratably each month thereafter.